XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Summary of financial information concerning the entity's reportable segments
 
Three Months Ended June 30, 2020
 
Reporting Segment
 
Corporate
and Other
 
 
(in thousands)
Healthcare
 
Research
 
 
Consolidated
Total revenue
$
84,382

 
$
11,459

 
$
3,268

 
$
99,109

Gross profit
56,341

 
4,426

 
760

 
61,527

Income/(loss) before income taxes
26,005

 
919

 
(23,987
)
 
2,937

Depreciation and amortization
8,962

 
923

 
994

 
10,879

Capital expenditures
8,692

 
395

 
1,039

 
10,126

 
Three Months Ended June 30, 2019
 
Reporting Segment
 
Corporate
and Other
 
 
(in thousands)
Healthcare
 
Research
 
 
Consolidated
Total revenue
$
95,004

 
$
13,879

 
$
2,920

 
$
111,803

Gross profit
64,387

 
5,335

 
518

 
70,240

Income/(loss) before income taxes
32,514

 
1,052

 
(20,459
)
 
13,107

Depreciation and amortization
8,327

 
1,004

 
861

 
10,192

Capital expenditures
9,080

 
1,306

 
372

 
10,758

 
Six Months Ended June 30, 2020
 
Reporting Segment
 
Corporate
and Other
 
 
(in thousands)
Healthcare
 
Research
 
 
Consolidated
Total revenue
$
180,089

 
$
25,279

 
$
6,772

 
$
212,140

Gross profit
120,765

 
10,101

 
1,169

 
132,035

Income/(loss) before income taxes
55,881

 
2,962

 
(43,573
)
 
15,270

Depreciation and amortization
17,397

 
1,989

 
1,978

 
21,364

Capital expenditures
14,903

 
786

 
1,421

 
17,110

 
Six Months Ended June 30, 2019
 
Reporting Segment
 
Corporate
and Other
 
 
(in thousands)
Healthcare
 
Research
 
 
Consolidated
Total revenue
$
183,013

 
$
26,843

 
$
5,926

 
$
215,782

Gross profit
124,251

 
9,669

 
1,098

 
135,018

Income/(loss) before income taxes
62,122

 
1,816

 
(41,219
)
 
22,719

Depreciation and amortization
16,618

 
1,932

 
1,663

 
20,213

Capital expenditures
13,522

 
1,788

 
782

 
16,092